Strategic Partnerships BioHorizons’ position as a leading dental implant and biologics company within Henry Schein suggests strong collaboration potential with dental distributors, clinics, and specialty practices. The Aug 2026 exclusive partnership with Xtant Medical to expand access to growth factors indicates openness to co-marketing and joint product launches that can extend reach into implantology and regenerative solutions.

Global Expansion With products available in 85 markets, BioHorizons demonstrates a broad regional footprint and international growth potential. Sales opportunities exist in emerging markets or regions where implant and regenerative solutions are gaining adoption, alongside localized training and support services.

Product Innovation Recent launches such as Pro Zygoma for immediate full-arch placement and SmartShape Healers point to a focus on procedural efficiency and advanced workflows. There are cross-sell opportunities to pair implants with planning software, tissue regeneration offerings, and supportive devices for complex surgeries.

Technology Stack Utilization of cloud and analytics platforms (Power BI, AWS, Azure, Dynamics) suggests readiness for data-driven partnerships, co-development of digital planning tools, and seamless EDI or CRM integrations to streamline orders, training, and post-sale support for clinicians.

Mid-Mize Growth Revenue scale in the $100M–$250M range and a relatively lean headcount compared to peers imply opportunities to upsell premium services, extended warranties, training programs, and bundled regeneration solutions to existing customers, channels, and practice groups seeking value optimization.